Related Experiment Video
Updated: Jun 24, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
[Ventricular arrhythmias and sudden cardiac death]
Insights
Sudden cardiac death (SCD) is often caused by ventricular arrhythmias. Implantable cardioverter-defibrillators (ICDs) are recommended for preventing SCD in heart attack patients with ventricular fibrillation.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Science
Context:
- Sudden cardiac death (SCD) is a non-traumatic, unexpected death due to cardiac causes.
- It is characterized by sudden loss of consciousness within an hour of symptom onset.
- Ventricular arrhythmias, including ventricular tachycardia and fibrillation, are primary risk factors for SCD.
Purpose:
- To outline the causes and risk factors of sudden cardiac death.
- To discuss the therapeutic strategies for managing ventricular arrhythmias.
- To highlight the role of specific treatments in preventing SCD.
Summary:
- Electrophysiological anomalies drive ventricular arrhythmias, leading to potential fibrillation and SCD.
- Treatment options include antiarrhythmic drugs, beta-blockers, amiodarone, lidocaine, sotalol, and catheter ablation.
- Implantable cardioverter-defibrillators (ICDs) are crucial for primary prevention of SCD in acute myocardial infarction patients with ventricular fibrillation.
Impact:
- Provides a concise overview of SCD pathophysiology and risk factors.
- Summarizes current treatment modalities for ventricular arrhythmias.
- Emphasizes the importance of ICDs in SCD prevention strategies.
Abstract:
Sudden cardiac death (SCD) - this natural death caused by cardiac reasons and which is characterized by sudden loss of consciousness within first hour after revealing of sharp clinical symptoms. A primary factor of SCD is not traumatic. It occurs suddenly and unexpectedly. The high risk of development of sudden cardiac death is basically associated with ventricular arrhythmias. Electrophysiological anomalies in cells lead to development of ventricular ectopic activity or ventricular tachycardia which comes to the end with fibrillation. The ultimate goal of antiarrhythmic drug therapy is to restore normal rhythm and conduction Treatment of ventricular arrhythmia provides application of antiarrhythmic medicines, beta-adrenoblokators, amiodarone, lidocaine, sotalole, implantation cardioverters - defibrillators (ID), catheter ablation, surgical manipulations. ID therapy is recommended for primary prevention developments SCD in patients with ventricular fibrillation against a background of the acute miocardial infarction.
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias II: Classification of Tachyarrhythmias
Mechanism of Cardiac Arrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
